Sun Pharmaceutical Industries Ltd. announced that U S Food and Drug Administration (US FDA) has granted approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Flomax , tamsulosin capsules.
These tamsulosin hydrochloride capsules, 0.4 mg are therapeutically equivalent to Flomax capsules 0.4 mg from Boehringer Ingelheim Pharmaceuticals, Inc.
Tamsulosin hydrochloride capsules are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH).
Flomax is a registered trademark of Astellas Pharma Inc.